{
    "eid": "2-s2.0-84994806854",
    "title": "Slow desensitization of imatinib-induced nonimmediate reactions and dynamic changes of drug-specific CD4+CD25+CD134+ lymphocytes",
    "cover-date": "2016-11-01",
    "subject-areas": [
        {
            "$": "Immunology",
            "@code": "2403"
        },
        {
            "$": "Immunology and Allergy",
            "@code": "2723"
        },
        {
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740"
        }
    ],
    "keywords": [],
    "authors": [
        "Jettanong Klaewsongkram"
    ],
    "citedby-count": 10,
    "ref-count": 26,
    "ref-list": [
        "Indications for imatinib mesylate therapy and clinical management",
        "Imatinib mesylate: In the treatment of gastrointestinal stromal tumours",
        "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia",
        "Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia",
        "The Complex Clinical Picture of Side Effects to Anticoagulation",
        "Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia",
        "Can We and Should We Improve on Frontline Imatinib Therapy for Chronic Myeloid Leukemia?",
        "Tyrosine kinase inhibitors - A review on pharmacology, metabolism and side effects",
        "Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor",
        "Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib",
        "Desensitization to imatinib in patients with leukemia",
        "Successful progressive challenge after a cutaneous reaction to imatinib mesylate (gleevec): A case report and review of the literature",
        "Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign",
        "Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor",
        "Imatinib induced Stevens-Johnson syndrome: Lack of recurrence following re-challenge with a lower dose [2]",
        "Desensitization for hypersensitivity reactions to medications",
        "Desensitization in delayed drug hypersensitivity reactions - An EAACI position paper of the Drug Allergy Interest Group",
        "Allopurinol hypersensitivity reactions: Desensitization strategies and new therapeutic alternative molecules",
        "Ox-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses",
        "Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system",
        "Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute               graft-versus-host disease in a murine model of allogeneic bone marrow transplantation",
        "Signaling through OX40 (CD134) breaks peripheral T-cell tolerance",
        null,
        null,
        null,
        "Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Research University",
        "Chulalongkorn University",
        "Chulalongkorn University"
    ]
}